PathAI Announces Collaboration With GSK On NASH Phase 2b Clinical Trial; Part Of Multi-Year Partnership Focusing On Drug Development In NASH And Oncology
Part of Multi-year Partnership Focusing on Drug Development in NASH and Oncology
BOSTON, March 30, 2023 /PRNewswire/ -- PathAI, a leading provider of AI-powered pathology, today announced its